Discovery of the Orally Effective Thyrotropin-Releasing Hormone Mimetic: 1-{N-[(4S,5S)-(5-Methyl-2-oxooxazolidine-4-yl)carbonyl]-3-(thiazol-4-yl)-l-alanyl}-(2R)-2-methylpyrrolidine...

por Kobayashi, Naotake, Sato, Norihito, Fujimura, Yuko, Kihara, Tsuyoshi, Sugita, Katsuji, Takahashi, Kouji, Koike, Katsumi, Sugawara, Tamio, Tada, Yukio, Nakai, Hiroshi, Yoshikawa, Takayoshi
Publicado 2018

Correction to Discovery of the Orally Effective Thyrotropin-Releasing Hormone Mimetic: 1-{N-[(4S,5S)-(5-Methyl-2-oxooxazolidine-4-yl)carbonyl]-3-(thiazol-4-yl)-l-alanyl}-(2R)-2-met...

por Kobayashi, Naotake, Sato, Norihito, Fujimura, Yuko, Kihara, Tsuyoshi, Sugita, Katsuji, Takahashi, Kouji, Koike, Katsumi, Sugawara, Tamio, Tada, Yukio, Nakai, Hiroshi, Yoshikawa, Takayoshi
Publicado 2019

Preclinical antitumor activity of S-222611, an oral reversible tyrosine kinase inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2

por Tanaka, Hidekazu, Hirata, Michinari, Shinonome, Satomi, Wada, Toru, Iguchi, Motofumi, Dohi, Keiji, Inoue, Makiko, Ishioka, Yukichi, Hojo, Kanji, Yamada, Tomomi, Sugimoto, Tatsuya, Masuno, Koichi, Nezasa, Ken-ichi, Sato, Norihito, Matsuo, Kenji, Yonezawa, Shuji, Frenkel, Eugene P, Shichijo, Michitaka
Publicado 2014